---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-000737"
form_type: "8-K"
ticker: "BVS"
cik: "0001665988"
company_name: "Bioventus Inc."
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T17:58:00.774827+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Bioventus appoints John A. Bartholdson to board as Class II director effective Jan 8, 2023

## Summary
- John A. Bartholdson, 52, co-founder and Partner at Juniper Investment Company, appointed to Bioventus board effective Jan 8, 2023.
- He will serve as Class II director until 2023 annual meeting or successor elected.
- Bartholdson receives annual cash retainer of $55,000 and initial RSU award valued at $152,000.
- He brings 25 years experience in private/public equity, currently chairs Theragenics board.

## SEC filing metadata
- accession: 0001628280-23-000737
- form_type: 8-K
- ticker: BVS
- cik: 0001665988
- company_name: Bioventus Inc.
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1665988/000162828023000737/0001628280-23-000737-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1665988/000162828023000737/bvs-20230108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-000737
- JSON: https://secwatch.observer/filing/0001628280-23-000737.json
- Plain text: https://secwatch.observer/filing/0001628280-23-000737.txt

## Key facts
- Executive change
  John A. Bartholdson was appointed as Class II Director at Bioventus Inc..
  - Action: appointed
  - Role: Class II Director
  source text: On January 8, 2023, the Board of Directors (the "Board") of Bioventus Inc. (the "Company") appointed John A. Bartholdson to the Board as a Class II director effective on January 8, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1665988/000162828023000737/0001628280-23-000737-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.